Stanford University


Showing 1,141-1,150 of 2,821 Results

  • Cary McClelland

    Cary McClelland

    Lecturer

    BioCary McClelland is a civil rights lawyer and award-winning writer and filmmaker who brings to
    his teaching a global experience of conflict resolution and a personal understanding of the role
    of storytelling in dispute resolution.

    As an attorney, Cary has worked primarily in defense of the freedom of expression and other
    civil rights, advancing prominent cases related to election misinformation, digital privacy rights,
    and disparities arising from Covid-19. He defended journalists and artists in various First
    Amendment suits, including Buzzfeed’s publication of the Christopher Steele dossier. He
    represented clients who fought to protect the private information of online users from
    government seizure and challenged the Trump administration’s travel ban against Muslim-
    majority countries. Most recently, he led a team of lawyers representing New York individuals
    and organizations who fought on behalf of communities disproportionately impacted by the
    Covid-19 in their action against the federal health agencies for their statutory failures during
    the pandemic.

    Prior to the law, Cary spent the first part of his career working on human rights and conflict
    resolution initiatives throughout the Middle East, Latin America, Africa, and Asia. He trained
    former child soldiers to be journalists in the Democratic Republic of Congo, worked alongside
    opposition activists in Zimbabwe, and collaborated on advocacy campaigns in Egypt, Syria, and
    Myanmar. He has a particular interest in traditional and restorative conflict transformation
    processes, and so has studied and supported the United Nations truth commission in East
    Timor and tribal courts in sub-Saharan Africa. Working with Witness and Google, he founded
    and launched a Webby-Award-winning media channel highlighting and protecting the work of
    citizen journalists around the world.

    Alongside these efforts, Cary has continued to document and bring to life stories of people
    persisting in turbulent times. His award-winning film, Without Shepherds, centers the lives of
    six people fighting against extremism in Pakistan, including the nation’s current Prime Minister
    Imran Khan as he launched his political party. Cary’s recent book Silicon City tells the story of
    San Francisco transformed by the tech industry and the new American economy through
    portraits of its citizens, past and present; it was chosen as one of Stanford University’s Three
    Books of 2019. Currently, he is completing a book on New York City’s experience of the Covid-
    19 pandemic and advancing another on grassroots populism in West Virginia.

    His research focuses on the role of narrative and data in rights advocacy, structural reform, and
    conflict resolution efforts throughout the United States and beyond. He is a frequently invited
    speaker on topics of media, technology, democracy, rule of law and storytelling.

  • Jay McClelland

    Jay McClelland

    Lucie Stern Professor in the Social Sciences, Professor of Psychology and, by courtesy, of Linguistics and of Computer Science

    Current Research and Scholarly InterestsMy research addresses topics in perception and decision making; learning and memory; language and reading; semantic cognition; and cognitive development. I view cognition as emerging from distributed processing activity of neural populations, with learning occurring through the adaptation of connections among neurons. A new focus of research in the laboratory is mathematical cognition and reasoning in humans and contemporary AI systems based on neural networks.

  • Conor McClune

    Conor McClune

    Postdoctoral Scholar, Chemical Engineering

    BioI develop systematic approaches for studying the plasticity of life at the molecular level, especially the bioactive compounds in plants we consume as food or medicine.

  • Emily Clair McClung, MD, FACOG

    Emily Clair McClung, MD, FACOG

    Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology

    BioDr. McClung is a fellowship trained, board certified Gynecologic Oncologist with the Stanford Medicine Cancer Center and Clinical Assistant Professor in the Stanford Medicine Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.

    She graduated from the Icahn School of Medicine at Mount Sinai in New York City and she completed residency in Obstetrics and Gynecology at Stanford Medicine. She then pursued sub-specialty Gynecologic Oncology fellowship at Moffitt Cancer Center and the University of South Florida in Tampa, Florida.

    Prior to joining Stanford Health Care, Dr. McClung was an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona Banner University Medical Center in Tucson, Arizona.

    Dr. McClung actively contributes to gynecologic cancer research. She has studied prevention of surgical site infections, gene expression prediction of lymph node metastasis in endometrial cancer, treatment resistance in ovarian cancer, and additional topics. She co-authored articles on her findings for peer-reviewed publications such as the International Journal of Gynecologic Cancer, International Journal of Women’s Health, and Gynecologic Oncology Reports.

    She authored the chapter on the diagnosis and management of vaginal cancer in the textbook Handbook of Gynecology and has made invited presentations at meetings of the Society of Gynecologic Oncology and other associations. She works to improve patient access to state-of-the-art care as an investigator in cooperative group clinical trials.

    She has won multiple teaching awards for her work with medical students and residents. She is passionate about increasing awareness of gynecologic cancer in medical trainees.

    Dr. McClung provides comprehensive care with a personalized approach for patients with gynecologic cancer and pre-cancer including surgery, chemotherapy, cancer risk reduction, and palliative care. She has a strong clinical interest in patient safety and quality of life both during and after cancer treatment.